Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Caphosol Artifical Saliva Tablets

K-Number: K162167 · 2017-03-31

Decision Date2017-03-31
Product CodeLFD
DecisionSubstantially Equivalent

Device Summary

Caphosol Artifical Saliva Tablets is a medical device manufactured by Eusa Pharma (Uk) Limited. It received FDA 510(k) clearance on 2017-03-31 under approval number K162167. The device is classified under product code LFD. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Caphosol Artifical Saliva Tablets?

Caphosol Artifical Saliva Tablets is a medical device that received FDA 510(k) clearance on 2017-03-31. It is manufactured by Eusa Pharma (Uk) Limited. The 510(k) number is K162167.

When was Caphosol Artifical Saliva Tablets approved by the FDA?

Caphosol Artifical Saliva Tablets received FDA 510(k) clearance on 2017-03-31, under approval number K162167.

What company makes Caphosol Artifical Saliva Tablets?

Caphosol Artifical Saliva Tablets is manufactured by Eusa Pharma (Uk) Limited.

What is the FDA product code for Caphosol Artifical Saliva Tablets?

The FDA product code for Caphosol Artifical Saliva Tablets is LFD.

Other Devices by Eusa Pharma (Uk) Limited

Related Devices (Code: LFD)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.